Cardiogen
Cardiac bioregulator peptide
Cardiac tissue bioregulator.
Half-life
~ hours
Mol. weight
~ 433.5 g/mol
Sequence
Ala-Glu-Asp-Arg (AEDR)
Discussions
0 threads
Overview
A short bioregulator peptide in the Khavinson tradition, proposed to regulate gene expression in cardiac tissue to support cardiomyocyte function and myocardial metabolism. As a tissue-targeted bioregulator, it represents the same transcriptional-regulation concept applied to the heart.
Mechanism of action
Cardiogen belongs to the Khavinson bioregulator class and is studied for regulating gene expression in cardiac tissue, with proposed support for cardiomyocyte function and myocardial metabolism. The proposed mechanism — ultra-short peptides modulating tissue-specific transcription in the heart — is the same conceptual framework as other bioregulators, distinct from receptor-mediated signaling.
Researched benefits
- Studied for cardiac tissue support
- Heart-targeted bioregulator format
- Proposed cardiomyocyte metabolism support
Considerations
- Evidence concentrated in one research tradition
- Human data limited
- Mechanism not fully established in mainstream literature
Key Academic Literature & Studies
Search more in PubMedPeer-reviewed citations and clinical trials evaluating Cardiogen in scientific literature.
Query PubMed for recent peer-reviewed preclinical and clinical publications on Cardiogen:
View Cardiogen index on PubMed (NCBI)